A University of Adelaide medical researcher says current treatment for people diagnosed with oesophageal cancer could be improved with additional pathology tests. Dr Sarah Thompson, a surgeon and PhD candidate, says tiny…
Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest
An experimental drug that targets a brain system that controls inflammation might help preserve neurological function in people who survive sudden cardiac arrest, new research suggests. Survival rates for sudden cardiac arrest…
Scientists discover new way to generate human motor nerve cells
Scientists have discovered a new way to generate human motor nerve cells in a development that will help research into motor neurone disease. A team from the Universities of Edinburgh, Cambridge and…
Bone marrow stem cell transplantation feasible, safe treatment for children with severe traumatic brain injury
For children with severe traumatic brain injury (TBI), transplantation of stem cells derived from the patients’ own bone marrow is a “logistically feasible and safe” treatment procedure, reports the March issue of…
NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax’s lead product entinostat, a novel inhibitor of histone deacetylases (HDAC),…
New research finds link between genomic variants in neurological processes and autism
New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have…
Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings
Thanks in part to a Norwegian research biobank, researchers have generated important new insight into ADHD and how the condition manifests itself. Among other things, they have found that there is some…
Nanotechnology holds promise for developing surgical measures
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may provide powerful new tools that could have a marked impact on the therapeutic and diagnostic measures available to surgeons….
Researchers discover three genes that contribute to abnormal growth
Geneticists unveil workings of 3 genes that control cell development and growth By working with Canadians of French ancestry who suffer a rare genetic disease, researchers have discovered how three genes contribute…
Study confirms risk of triple-negative breast cancer among obese, physically inactive women
New findings published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, confirm the risk of breast cancer among women who are obese and not physically…
Enzyme that metabolizes vitamin D can predict lung cancer survival
Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer…
Researcher Instigates Cancer Cell Suicide
A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has…
New CPR method improves long-term survival rates in patients with cardiac arrest by 50%
A five-year clinical trial led by University of Minnesota Medical School researchers has led to a new method of cardiopulmonary resuscitation (CPR) that improves long-term survival rates with good brain function by…
European Commission approves BMY’s BARACLUDE(r) to treat CHB in adult patients with liver disease
Bristol-Myers Squibb (NYSE: BMY) announced today that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients with evidence of…
FDA clears Valeritas’ V-Go Disposable Insulin Delivery Device for use with NovoLog
Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company’s V-Go Disposable…